Dr. Thomas M Baer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 307 Main St, Malvern, IA 51551 Phone: 712-624-6010 Fax: 712-357-2101 |
News Archive
Thanks to a $1.2 million grant from the Swedish International Development Cooperation Agency (SIDA), a York University-based group of international researchers are pressing ahead with plans to develop a system for monitoring and promoting human rights for people with disabilities around the world.
Researchers at the University of Illinois have developed a method for culturing mammalian neurons in chambers not much larger than the neurons themselves.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
As the oldest of the baby boomers begin to reach retirement age, a large percentage of Americans are thinking more and more about how much money they must save to be able to retire comfortably. Also, more and more employers are changing retirement benefits from defined-benefit plans, which guarantee some level of retirement income, to defined-contribution plans, which require employees to invest on their own for retirement.
DelMar Pharmaceuticals, Inc., announced today that the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for its lead product candidate, VAL-083, in the treatment of medulloblastoma.
› Verified 5 days ago